Loading, Please Wait...
BEVERLY HILLS, CA--(Marketwired - Mar 15, 2016) - VitaCig, Inc. (
Outgoing CEO Paul Rosenberg comments, "As VitaCig opens this new chapter, the VitaCig Board and I are confident that Mr. Kassel is the right person to lead the company forward. Mr. Kassel's industry specific knowledge, contacts, sales experience, and complimentary management and leadership style will greatly benefit the entire organization. I pass the baton with much confidence that I have laid a great foundation for Glenn to build upon. VitaCig has never been so well positioned to succeed and drive revenues, as it is today. Lastly, I have no doubt Mr. Kassel will continue to prioritize shareholders, build company value, and avoid toxic financing and highly dilutive transactions just as I have. We are thrilled that he has joined the VitaCig team and know that our shareholders will be thrilled as well."
Glenn is an entrepreneur with a strong business mind, providing time and leadership with several large successful Corporations (including Mobil Oil, McDonald's Worldwide, Disney, Wendy's, and Denny's). He has a track record of scaling revenues and increasing profits, all while building solid sales and operational teams. Glenn was an pioneer in the vaping industry, long before 'Vape' became Oxford Dictionary's Word of the Year 2014. In 2008, Glenn became President and Co-Founder of Freedom Smokeless, Inc., an importer of components and OEM manufacturer for the electronic cigarette industry. Originally producing their own Freedom Smokeless brand and private labeling for others, Freedom changed course in 2011 and focused mainly on the manufacturing side of the industry. Freedom created the first automated e-liquid filling machines in the U.S. Using only U.S. made e-liquid and U.S. packaging services, he proudly brought jobs back here to the U.S.
Glenn is the longest tenured member on the Board of Directors of SFATA (Smoke-Free Alternatives Trade Association), which is the largest group (almost 1000 members) representing the vaping industry. He has been active in speaking at the FDA, as well as being active in State and Federal lobbying to educate legislators and regulatory organizations about vapor products.
Newly appointed CEO Glenn Kassel comments, "I am honored and excited to join VitaCig, Inc. as their Chief Executive Officer. I am humbled to be in a position to build and protect shareholder value. I look forward to helping the VitaCig team capitalize on numerous domestic and international opportunities that are available for their expanding product lines. Having extensive experience in the electronic cigarette industry since 2008, and deep understanding of the CBD sciences and Industry, I know that I can add value to the company when it comes to supply chain management, product development, product safety, and sales. I feel that VitaCig is uniquely positioned to capture a nice share of a still, growing and trending industry. I am also extremely excited about the prospects for VitaCig's VitaCBD Division. CBD sciences, and the growing public awareness and reception for CBD in general, has explosive growth potential, in my opinion. I Iook forward to helping the company increase their market presence and profitability, and I am excited to build on the strong foundation that Paul has laid out as we turn a new chapter in the Company's young history. Shareholders have a lot to look forward to, thank you in advance for your support."
About VitaCig, Inc.
VitaCig, Inc. (
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.